Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joshua Bilenker Insider Profile
11 Followers
Joshua Bilenker, President & CEO, Director at Loxo Oncology, holds 0.00 shares in Loxo Oncology (Ticker: LOXO), holds 7.46M shares in Viewray (Ticker: VRAYQ), holds ― shares in Gossamer Bio (Ticker: GOSS).
Joshua Bilenker Loxo Oncology (LOXO)President & CEO, Director
Loxo Oncology (LOXO)
President & CEO, Director
Ranked #22,048 out of 98,624 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+101.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joshua Bilenker holds in companies
Most Profitable Insider Trade
The most profitable trade made by Joshua Bilenker
Joshua Bilenker's Trading History
Loxo Oncology
Feb 15, 2019
―
Uninformative Sell
45.29M
$0.00
Viewray
Sep 15, 2016
Director, Ten Percent Owner
Uninformative Buy
―
$89.54K
Gossamer Bio
―
Director
―
―
Sana Biotechnology
Feb 17, 2023
Director
Informative Buy
500.00K
$192.60K
T2 Biosystems
―
Director
―
$0.00
Sorrento Tech Inc
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Joshua Bilenker's performance on stock
You May Also Like
Joshua Bilenker insider profile FAQ
What is the percentage of profitable transactions made by Joshua Bilenker?
The percentage of profitable transactions made by Joshua Bilenker is 100%.
What is the average return per transaction made by Joshua Bilenker?
The average return per transaction made by Joshua Bilenker is 101.20%.
What stocks does Joshua Bilenker hold?
Joshua Bilenker holds: LOXO, VRAYQ, GOSS, SANA, TTOO, ROKA stocks.
What was Joshua Bilenker’s latest transaction?
Joshua Bilenker latest transaction was an Uninformative Sell of $45.29M.
What was Joshua Bilenker's most profitable transaction?
Joshua Bilenker’s most profitable transaction was an Informative Buy of VRAYQ stock on March 30, 2016. The return on the trade was 104.30%.
What is Joshua Bilenker's role in Loxo Oncology?
Joshua Bilenker's role in Loxo Oncology is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.